| 1 | 23658947 | Optimization and characterization of a triazole urea dual inhibitor for lysophospholipase 1 (LYPLA1) and lysophospholipase 2 (LYPLA2) | | 2010 |
2 |
| 2 | 23658950 | Optimization and characterization of a triazole urea inhibitor for diacylglycerol lipase beta (DAGL-β) | | 2010 |
1 |
| 3 | 23658953 | Optimization and characterization of a triazole urea inhibitor for alpha/beta hydrolase domain-containing protein 11 (ABHD11): anti-probe for LYPLA1/LYPLA2 dual inhibitor ML211 | | 2010 |
7 |
| 4 | 23658960 | Optimization and characterization of a triazole urea inhibitor for platelet-activating factor acetylhydrolase type 2 (PAFAH2) | | 2010 |
2 |
| 5 | 26589672 | The Arabidopsis ABHD11 Mutant Accumulates Polar Lipids in Leaves as a Consequence of Absent Acylhydrolase Activity. | Plant Physiol | 2016 Jan |
2 |
| 6 | 28465236 | Human alpha beta hydrolase domain containing protein 11 and its yeast homolog are lipid hydrolases. | Biochem Biophys Res Commun | 2017 Jun 10 |
4 |
| 7 | 30429229 | Long non-coding RNA ABHD11-AS1 promotes colorectal cancer development through regulation of miR-133a/SOX4 axis. | Biosci Rep | 2018 Dec 21 |
1 |
| 8 | 32792488 | ABHD11 maintains 2-oxoglutarate metabolism by preserving functional lipoylation of the 2-oxoglutarate dehydrogenase complex. | Nat Commun | 2020 Aug 13 |
1 |
| 9 | 34446052 | Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer. | J Transl Med | 2021 Aug 26 |
3 |
| 10 | 35186240 | LncRNA ABHD11-AS1 Participates in the Progression of Cervical Carcinoma by Targeting miR-1254 and Is the Key to the Diagnosis and Treatment of Cervical Carcinoma in the Future. | J Healthc Eng | 2022 |
2 |
| 11 | 35314614 | ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies. | Noncoding RNA | 2022 Mar 1 |
1 |